“…Similar to flavokavain A, flavokavain B was reported to inhibit cancer cell proliferation [ 118 ], metastasis [ 128 , 129 ] and angiogenesis [ 130 ], and induce apoptosis [ 128 , 129 , 131 , 132 , 133 , 134 , 135 , 136 ], G2/M [ 128 , 132 , 136 , 137 ], G0/G1 [ 138 ] cell cycle arrest, autophagy [ 134 , 139 , 140 , 141 , 142 ], and the immune responses [ 143 ]. Unlike flavokavain A, flavokavain B induced G2/M cell cycle arrest in cancer cells regardless of the p53 status [ 128 , 131 , 132 , 134 , 136 , 137 ], which is intriguing given their similar structures ( Figure 2 ). Flavokavain B has also been reported to inhibit the uridine-cytidine kinase 2 (UCK2) enzyme in HT-29 cells, resulting in G0/G1 cell cycle arrest and subsequently led to cancer cell death through the MDM2-p53 signaling pathway (50 μM) [ 138 ].…”